anmelden
SMI Equal Weight
380,39
PKT
+2,16
PKT
+0,57
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Equal Weight-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.07.12 | Novartis neutral | Citigroup Corp. | |
| 11.07.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 11.07.12 | Logitech outperform | Exane-BNP Paribas SA | |
| 11.07.12 | Kühne + Nagel International buy | Nomura | |
| 11.07.12 | Swiss Life buy | Vontobel Research | |
| 10.07.12 | Logitech neutral | Sarasin Research | |
| 10.07.12 | Logitech hold | Vontobel Research | |
| 09.07.12 | Nestlé reduce | Nomura | |
| 09.07.12 | Holcim hold | Vontobel Research | |
| 06.07.12 | UBS overweight | HSBC | |
| 06.07.12 | Swiss Re neutral | HSBC | |
| 06.07.12 | UBS overweight | HSBC | |
| 05.07.12 | Novartis buy | Deutsche Bank AG | |
| 05.07.12 | Swiss Re hold | Société Générale Group S.A. (SG) | |
| 05.07.12 | Kühne + Nagel International hold | Vontobel Research | |
| 04.07.12 | Swiss Re neutral | Exane-BNP Paribas SA | |
| 04.07.12 | Holcim sell | Goldman Sachs Group Inc. | |
| 04.07.12 | Holcim neutral | Goldman Sachs Group Inc. | |
| 04.07.12 | Givaudan sell | Deutsche Bank AG | |
| 04.07.12 | Kühne + Nagel International overweight | J.P. Morgan Cazenove | |
| 03.07.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 03.07.12 | Zurich Insurance buy | Nomura | |
| 03.07.12 | Swiss Re buy | Sarasin Research | |
| 03.07.12 | Nestlé kaufen | Norddeutsche Landesbank (Nord/LB) | |
| 03.07.12 | Kühne + Nagel International hold | Vontobel Research | |
| 02.07.12 | Nestlé neutral | Goldman Sachs Group Inc. | |
| 02.07.12 | Geberit kaufen | Euro am Sonntag | |
| 02.07.12 | UBS hold | ING | |
| 02.07.12 | UBS sell | ING | |
| 02.07.12 | Swisscom hold | Vontobel Research | |
| 29.06.12 | Nestlé sector perform | RBC Capital Markets | |
| 28.06.12 | Novartis buy | Deutsche Bank AG | |
| 28.06.12 | UBS neutral | Sarasin Research | |
| 28.06.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 27.06.12 | UBS overweight | J.P. Morgan Cazenove | |
| 27.06.12 | Kühne + Nagel International outperform | Credit Suisse Group | |
| 27.06.12 | Sika buy | Vontobel Research | |
| 26.06.12 | Swiss Life neutral | Goldman Sachs Group Inc. | |
| 26.06.12 | ABB (Asea Brown Boveri) neutral | Exane-BNP Paribas SA | |
| 26.06.12 | UBS outperform | RBC Capital Markets |